Capricor Therapeutics reported $47.5M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Bluebird Bio BLUE:US USD 160.44M 7.02M
Capricor Therapeutics CAPR:US USD 47.5M 5.12M
Cytokinetics CYTK:US USD 884.28M 282.02M
Cytori Therapeutics CYTX:US USD 20.88M 1.99M
Geron GERN:US USD 222.07M 5.3M
Newlink Genetics NLNK:US USD 78.83M 6.16M
Prothena PRTA:US USD 524.56M 3.27M
Ptc Therapeutics PTCT:US USD 517.26M 177.41M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Vascular Biogenics VBLT:US USD 27.53M 8.16M
Vital Therapies VTL:US USD 86.65M 18.11M